Ramesh Juneja: The Trailblazer Who Revolutionized Affordable Healthcare in India

Major Events Of M.A. Yusuff Ali’s Life

  • 1948: Ramesh Juneja is born in Haryana, India.
  • 1968: Ramesh Juneja completes his Bachelor’s degree in Science from Kurukshetra University.
  • 1970: Ramesh Juneja completes his Master’s degree in Chemistry from Kurukshetra University.
  • 1986: Ramesh Juneja founds Mankind Pharma with a vision to provide affordable and high-quality medicines to people in India.
  • 1995: Mankind Pharma launches its first product, Amoxicillin, an antibiotic drug.
  • 2000: Mankind Pharma introduces a range of cardiovascular drugs.
  • 2005: Mankind Pharma expands its operations to include manufacturing facilities in 11 locations across India.
  • 2007: Mankind Pharma starts exporting its products to international markets, including Africa, Asia, and Latin America.
  • 2011: Mankind Pharma becomes one of the top ten pharmaceutical companies in India.
  • 2015: Ramesh Juneja is honored with the Ernst & Young Entrepreneur of the Year award for his contributions to the pharmaceutical industry.
  • 2016: Mankind Pharma becomes the first Indian company to manufacture a drug for the treatment of HIV/AIDS.
  • 2019: Mankind Pharma launches its first biosimilar drug, Rituximab, for the treatment of cancer.
  • 2020: Mankind Pharma plays an active role in India’s fight against COVID-19 by producing and distributing essential medicines and medical supplies.

Ramesh Juneja has been recognized for his contributions to the Indian pharmaceutical industry and for his philanthropic work. Today, Mankind Pharma is one of India’s leading pharmaceutical companies, with a wide range of products and a strong presence in both domestic and international markets. Ramesh Juneja is an Indian businessman who is known for his contributions to the pharmaceutical industry. He is the founder of Mankind Pharma, one of India’s leading pharmaceutical companies.